Neng Wang
Impact in
- Drug Discovery top 2%
- Biomaterials top 1%
- Advanced Cellulose Research Studies
Papers in
- Hepatology 14
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Oncology 22
- Cancer Cells and Metastasis 13
- Co-authors
- Zhiyu Wang (54 shared papers)Enyong Ding (4 shared papers)Rongshi Cheng (4 shared papers)Shengqi Wang (38 shared papers)Yifeng Zheng (37 shared papers)Jianping Chen (18 shared papers)Fengxue Zhang (15 shared papers)Xuan Wang (12 shared papers)
- Journals
- Frontiers in Pharmacology (6 papers)Oncotarget (6 papers)Phytomedicine (5 papers)Cell Death and Disease (5 papers)Frontiers in Oncology (4 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Neng Wang
133 papers receiving 6.3k citations
Neng Wang's Hit Papers
Peers
Comparison fields: 5 of 135
- Drug Discovery 22
- Biomaterials 787
- Cancer Research 719
- Oncology 994
- Hepatology 356
Countries citing papers authored by Neng Wang
This map shows the geographic impact of Neng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neng Wang more than expected).
Fields of papers citing papers by Neng Wang
This network shows the impact of papers produced by Neng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neng Wang. The network helps show where Neng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Neng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 563 | |
| 2 | Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients Hit paper breakdown → | 2020 | 357 |
| 3 | 2018 | 258 | |
| 4 | A Review: The Pharmacology of Isoliquiritigenin Hit paper breakdown → | 2015 | 243 |
| 5 | 2020 | 230 | |
| 6 | 2013 | 216 | |
| 7 | 2014 | 202 | |
| 8 | 2012 | 188 | |
| 9 | 2012 | 146 | |
| 10 | 2011 | 142 | |
| 11 | 2007 | 141 | |
| 12 | 2015 | 139 | |
| 13 | 2013 | 129 | |
| 14 | 2018 | 111 | |
| 15 | 2018 | 109 | |
| 16 | 2014 | 101 | |
| 17 | 2019 | 99 | |
| 18 | 2019 | 99 | |
| 19 | 2021 | 93 | |
| 20 | 2016 | 92 |
About Neng Wang
Neng Wang is a scholar working on Hepatology, Oncology, Cancer Research, Cell Biology and Molecular Biology, having authored 152 papers that have together received 6.4k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (13 papers), Immune cells in cancer (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Caveolin-1 and cellular processes (9 papers), Bioactive Natural Diterpenoids Research (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Autophagy in Disease and Therapy (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). The work is most often cited by research in Drug Discovery (22 citations), Biomaterials (787 citations), Cancer Research (719 citations), Oncology (994 citations) and Hepatology (356 citations). Neng Wang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Zhiyu Wang, Enyong Ding, Rongshi Cheng, Shengqi Wang, Yifeng Zheng, Jianping Chen, Fengxue Zhang, Xuan Wang, Juping Zhang and Yi Heng Lin. Their work appears in journals such as Frontiers in Pharmacology, Oncotarget, Phytomedicine, Cell Death and Disease and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.